Clinical Trials for Spinal Muscular Atrophy

Find clinical trials for spinal muscular atrophy. Discover research opportunities and treatment options in your area.

29 Active Trials Found

Showing 29 trials on this page

Page 2 of 2

Outpatient Rehabilitation Intervention for Young Children With SMA

NCT ID: NCT05638750

This clinical trial is looking at a special rehabilitation program for young children with Spinal Muscular Atrophy (SMA), a condition that affects muscle strength and movement. The study involves c...

Recruiting

Phase: NA Type: interventional Locations: Toronto, Ontario, Canada

Spinal Muscular Atrophy Neonatal Screening Program

NCT ID: NCT06310421

The Spinal Muscular Atrophy Neonatal Screening Program is a clinical trial aimed at finding out if screening newborns for spinal muscular atrophy (SMA) can help identify the condition early. SMA is...

Recruiting

Type: observational Locations: Trieste, , Italy, Monfalcone, Gorizia, Italy

Neonatal Spinal Muscular Atrophy (SMA) Screening

NCT ID: NCT03217578

This clinical trial is studying a screening test for Spinal Muscular Atrophy (SMA) in newborns. SMA is a genetic condition that affects muscle strength and movement. The trial is looking to identif...

Recruiting

Type: observational Locations: Kaohsiung, , Taiwan

MAP THE SMA: a Machine-learning Based Algorithm to Predict THErapeutic Response in Spinal Muscular Atrophy

NCT ID: NCT05769465

The MAP THE SMA clinical trial is looking to improve how we predict which treatments work best for patients with Spinal Muscular Atrophy (SMA). SMA is a genetic condition that affects the spinal co...

Recruiting

Type: observational Locations: Roma, , Italy

Development of a Multidisciplinary Network for Clinical and Laboratory Research for SMA

NCT ID: NCT05866939

This clinical trial aims to better understand spinal muscular atrophy (SMA), a condition that affects movement and muscle strength. Researchers want to observe how different types of SMA (Type I, I...

Not yet recruiting

Type: observational

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

NCT ID: NCT05824169

This clinical trial is testing a new gene therapy drug called GC101 to see if it is safe and effective for treating infants with Spinal Muscular Atrophy (SMA) Type 1. SMA is a genetic condition tha...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shenyang, Liaoning, China, Suzhou, , China +2 more

Long Term Trajectories of SMA Patients Receiving or Not Disease-modifying Treatments

NCT ID: NCT05768048

This clinical trial is studying the long-term effects of spinal muscular atrophy (SMA) treatments, both for patients who are receiving new therapies and those who are not. The goal is to understand...

Recruiting

Type: observational Locations: Rome, , Italy, Rome, , Italy +3 more

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

NCT ID: NCT05663008

This clinical trial is studying a new way to diagnose motor neuron diseases like ALS (Amyotrophic Lateral Sclerosis), Postpoliomyelitis Syndrome, and Spinal Muscular Atrophy. The researchers aim to...

Recruiting

Type: observational Locations: Dublin, Leinster, Ireland

A Registered Cohort Study on SMA

NCT ID: NCT04010604

This clinical trial is focused on understanding spinal muscular atrophy (SMA), a genetic condition that leads to muscle weakness and wasting. The study aims to gather more information about how SMA...

Recruiting

Type: observational Locations: Fuzhou, Fujian, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions